Clinical trial Recruiting at 1 site Interventional Ages 18 to 85

Imaging techniques to improve treatment of heart rhythm disorders

Official title: Peri-Procedural Transmural Electrophysiological Imaging of Scar-Related Ventricular Tachycardia

Run by Nova Scotia Health Authority · NCT03713866 · Data updated 2026-11-12

This study is testing if advanced imaging techniques can help doctors better treat heart rhythm problems in patients who have had a heart attack.

More Myocardial Infarction trials

Quick facts

Study typeInterventional
Ages18 Years to 85 Years
SexAll
Enrollment20 (estimated)
SponsorNova Scotia Health Authority
Academic / other
Locations1 site (Halifax, Nova Scotia)
StatusRecruiting
StartedNovember 1, 2019
Main results expectedDecember 31, 2026
Study endsMarch 31, 2027
Registry record updatedMarch 17, 2026
Trial IDNCT03713866 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients with a history of sustained monomorphic ventricular tachycardia who have been referred for catheter ablation and have a previously implanted ICD.

Probably not a fit

Patients with severe renal impairment, life expectancy under six months, or contraindications to catheter ablation will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the use of advanced imaging techniques to enhance the treatment of ventricular tachycardia (VT) in patients with myocardial infarction. It aims to integrate functional VT data with 3D imaging from CT or MRI to better visualize the electrical circuits involved in VT. A total of 40 patients referred for catheter ablation will undergo noninvasive imaging and stimulation studies before and after the ablation procedure. The goal is to improve the identification of ablation targets and assess the outcomes of the treatment.

Why it matters

Potential benefit: If successful, this approach could lead to more effective ablation procedures and improved outcomes for patients with scar-related ventricular tachycardia.

How similar studies have gone: Other studies have shown promise in using advanced imaging techniques for cardiac conditions, suggesting potential success for this novel approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* One or more episodes of sustained monomorphic VT
* Referred for catheter ablation
* Previously implanted ICD
* Signed the patient informed consent form
* Able and willing to comply with all pre-, post-, and follow-up testing and requirements

Exclusion Criteria:

* Have estimated Glomerular Filtration Ratio (eGFR) less than 30
* Have a life expectancy less than 6 months or are listed for heart transplantation at time of inclusion
* Are pregnant
* Are on IV inotropic agents
* Have any contraindication to catheter ablation (including but not limited to mechanical prosthetic aortic and mitral valves, known protruding Left Ventricular (LV) thrombus
* New York Heart Association (NYHA) functional class IV
* Had ST wave elevation myocardial infarction within \< 1 month
* Unwilling or unable to undergo cardiac MRI scan AND unwilling or unable to undergo cardiac CT scan (e.g. contrast allergy).

Where it's running

  • Qeii Hsc
    Halifax, Nova Scotia, Canada
    Recruiting

Study contacts

  • Principal investigator: John L Sapp, MD FRCPC — Nova Scotia Health Authority
  • Study coordinator: John L Sapp, MD FRCPC
  • Email: john.sapp@nshealth.ca
  • Phone: 902 473 4272

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.